Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 13

1.

Homophilic CD44 Interactions Mediate Tumor Cell Aggregation and Polyclonal Metastasis in Patient-Derived Breast Cancer Models.

Liu X, Taftaf R, Kawaguchi M, Chang YF, Chen W, Entenberg D, Zhang Y, Gerratana L, Huang S, Patel DB, Tsui E, Adorno-Cruz V, Chirieleison SM, Cao Y, Harney AS, Patel S, Patsialou A, Shen Y, Avril S, Gilmore HL, Lathia JD, Abbott DW, Cristofanilli M, Condeelis JS, Liu H.

Cancer Discov. 2019 Jan;9(1):96-113. doi: 10.1158/2159-8290.CD-18-0065. Epub 2018 Oct 25.

PMID:
30361447
2.

The lncRNA BORG Drives Breast Cancer Metastasis and Disease Recurrence.

Gooding AJ, Zhang B, Jahanbani FK, Gilmore HL, Chang JC, Valadkhan S, Schiemann WP.

Sci Rep. 2017 Oct 5;7(1):12698. doi: 10.1038/s41598-017-12716-6.

3.

Integrated Diagnostics: The Computational Revolution Catalyzing Cross-disciplinary Practices in Radiology, Pathology, and Genomics.

Lundstr├Âm CF, Gilmore HL, Ros PR.

Radiology. 2017 Oct;285(1):12-15. doi: 10.1148/radiol.2017170062. Review. No abstract available.

PMID:
28926318
4.

In Reply.

Bomeisl PE, Gilmore HL.

Arch Pathol Lab Med. 2016 Nov;140(11):1185-1186. No abstract available.

PMID:
27788051
5.

c-Abl inhibits breast cancer tumorigenesis through reactivation of p53-mediated p21 expression.

Morrison CD, Allington TM, Thompson CL, Gilmore HL, Chang JC, Keri RA, Schiemann WP.

Oncotarget. 2016 Nov 8;7(45):72777-72794. doi: 10.18632/oncotarget.11909.

6.

Comparison of Oncotype DX Recurrence Score by Histologic Types of Breast Carcinoma.

Bomeisl PE, Thompson CL, Harris LN, Gilmore HL.

Arch Pathol Lab Med. 2015 Dec;139(12):1546-9. doi: 10.5858/arpa.2014-0557-OA.

PMID:
26619027
7.

In Reply.

Elliott RM, Shenk RR, Thompson CL, Gilmore HL.

Arch Pathol Lab Med. 2015 Jul;139(7):845-6. doi: 10.5858/arpa.2014-0530-LE. No abstract available.

PMID:
26125421
8.

Amyloid-╬▓ precursor protein promotes cell proliferation and motility of advanced breast cancer.

Lim S, Yoo BK, Kim HS, Gilmore HL, Lee Y, Lee HP, Kim SJ, Letterio J, Lee HG.

BMC Cancer. 2014 Dec 10;14:928. doi: 10.1186/1471-2407-14-928.

9.

Touch preparations for the intraoperative evaluation of sentinel lymph nodes after neoadjuvant therapy have high false-negative rates in patients with breast cancer.

Elliott RM, Shenk RR, Thompson CL, Gilmore HL.

Arch Pathol Lab Med. 2014 Jun;138(6):814-8. doi: 10.5858/arpa.2013-0281-OA.

PMID:
24878021
10.
11.

Stereotactic core biopsy: Comparison of 11 gauge with 8 gauge vacuum assisted breast biopsy.

Venkataraman S, Dialani V, Gilmore HL, Mehta TS.

Eur J Radiol. 2012 Oct;81(10):2613-9. doi: 10.1016/j.ejrad.2011.10.027. Epub 2011 Nov 27.

PMID:
22127375
12.

The association between vascular endothelial growth factor expression in invasive breast cancer and survival varies with intrinsic subtypes and use of adjuvant systemic therapy: results from the Nurses' Health Study.

Liu Y, Tamimi RM, Collins LC, Schnitt SJ, Gilmore HL, Connolly JL, Colditz GA.

Breast Cancer Res Treat. 2011 Aug;129(1):175-84. doi: 10.1007/s10549-011-1432-3. Epub 2011 Mar 9.

13.

Endocervical curettage; an aid in the diagnosis of early cervical cancer.

CLARKE L, GILMORE HL Jr.

Obstet Gynecol. 1956 Jun;7(6):634-45. No abstract available.

PMID:
13322365

Supplemental Content

Loading ...
Support Center